We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSHP
RNS Number : 5253M
J.P. Morgan Securities LLC
08 January 2019
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: J.P. Morgan Securities LLC (b) Name of offeror/offeree in relation to whose relevant Shire Plc securities this form relates: Use a separate form for each offeror/offeree ---------------------------------------------------------- (c) Name of the party to the offer with which exempt Joint Financial Adviser to Takeda Pharmaceutical Company principal trader is connected: Limited ---------------------------------------------------------- (d) Date position held/dealing undertaken: 07 January 2019 For an opening position disclosure, state the latest practicable date prior to the disclosure ---------------------------------------------------------- (e) In addition to the company in 1(b) above, is the Yes, Takeda Pharmaceutical Company Limited exempt principal trader making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" ---------------------------------------------------------- 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: Ordinary 5p Interests Short positions ----------------- ------------------ Number % Number % ---------- ----- ----------- ----- (1) Relevant securities owned and/or controlled: 1,536,708 0.17 309,069 0.03 ---------- ----- ----------- ----- (2) Cash-settled derivatives: 308,487 0.03 192,096 0.02 ---------- ----- ----------- ----- (3) Stock-settled derivatives (including options) and agreements to purchase/sell: 1,096,800 0.12 1,792,200 0.20 ---------- ----- ----------- ----- TOTAL: 2,941,995 0.32 2,293,365 0.25 ---------- ----- ----------- -----
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit security securities paid/received paid/received (USD) (USD) ADR Purchases 6,082 90.9900 90.9900 Sales 32,256 90.9900 90.9900 ----------------- ------------------------ ----------------------- ----------------------- (b) Cash-settled derivative transactions Class of relevant Product description Nature of dealing Number of reference Price per unit security e.g. CFD e.g. opening/closing a securities (USD) long/short position, increasing/reducing a long/short position (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry date Option money relevant description purchasing, securities price per e.g. paid/ security e.g. call selling, to which unit American, received per option varying etc. option (USD) European unit relates etc. (USD) (ii) Exercise Class of relevant Product description Exercising/ exercised Number of securities Exercise price per security e.g. call option against unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing Details Price per unit (if applicable) e.g. subscription, conversion 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? YES Date of disclosure: 08 January 2019 Contact name: Alwyn Basch ---------------- Telephone number: 020 7742 7407 ----------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION Full name of person making disclosure: J.P. Morgan Securities LLC Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Shire Plc --------------------------- 2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS) Class of Product Written or Number of Exercise price Type Expiry date relevant description purchased securities to per unit e.g. American, security e.g. call which option (USD) European etc. option or derivative relates ADS Call Option Written 50,000 140.00 American 18/01/2019
Call Option Written 185,000 170.00 American 18/01/2019 Call Option Purchased 16,900 160.00 American 18/01/2019 Call Option Written 162,000 130.00 American 18/01/2019 Call Option Written 110,000 180.00 American 18/01/2019 Call Option Purchased 85,000 180.00 American 19/07/2019 Call Option Purchased 188,000 200.00 American 18/01/2019 Call Option Written 94,000 200.00 American 18/04/2019 Call Option Written 50,000 165.00 American 18/01/2019 Call Option Written 11,100 190.00 American 18/01/2019 Call Option Written 23,300 195.00 American 18/01/2019 Put Option Purchased 10,000 150.00 American 18/01/2019 Put Option Written 72,600 180.00 American 18/04/2019 Put Option Purchased 78,000 165.00 American 18/01/2019 Put Option Written 3,100 170.00 American 18/01/2019 --------------- ---------------- --------------- ---------------- ---------------- ------------ 3. AGREEMENTS TO PURCHASE OR SELL ETC. Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FEOEAFFPEDANEFF
(END) Dow Jones Newswires
January 08, 2019 06:33 ET (11:33 GMT)
1 Year Shire Chart |
1 Month Shire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions